Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CALCIBIND | Mission Pharmacal | N-018757 DISCN | 1982-12-28 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
bio skin crystal bio-cellulose mask | OTC monograph final | 2015-09-23 |
hankki ssog pre-biome shake (detox and diet shake) | unapproved drug other | 2025-05-28 |
lacrisert | New Drug Application | 2024-07-25 |
limulus bio cellulose mask | unapproved drug other | 2017-06-28 |
miracle of skin | unapproved drug other | 2018-03-23 |
optase allegro | C200263 | 2024-12-17 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 28 | 6 | 3 | 2 | 50 | 86 |
Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 11 | 3 | 8 | 26 | 50 |
Syndrome | D013577 | — | — | 4 | 15 | 8 | 6 | 23 | 49 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 3 | 17 | 6 | 7 | 10 | 41 |
Overweight | D050177 | — | E66.3 | 2 | 3 | 3 | 1 | 31 | 39 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 11 | 4 | 6 | 12 | 36 |
Infections | D007239 | EFO_0000544 | — | 3 | 10 | 7 | 3 | 13 | 36 |
Inflammation | D007249 | MP_0001845 | — | 3 | 6 | — | 3 | 21 | 32 |
Hypertension | D006973 | EFO_0000537 | I10 | 3 | 5 | 2 | 3 | 15 | 27 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | 2 | 19 | 22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Communicable diseases | D003141 | — | — | 2 | 6 | 6 | — | 10 | 24 |
Covid-19 | D000086382 | — | U07.1 | 4 | 12 | 8 | — | 3 | 22 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | 6 | 1 | — | 11 | 18 |
Fatty liver | D005234 | EFO_0003934 | — | 2 | 6 | 2 | — | 7 | 16 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | 4 | 2 | — | 8 | 15 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 4 | 5 | 2 | — | 5 | 15 |
Hiv infections | D015658 | EFO_0000764 | B20 | 6 | 4 | 4 | — | — | 14 |
Sleep | D012890 | GO_0030431 | — | — | 2 | 3 | — | 8 | 12 |
Ulcer | D014456 | MPATH_579 | — | 2 | 1 | 5 | — | 4 | 12 |
Body weight | D001835 | EFO_0004338 | — | 1 | 1 | 1 | — | 10 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fatigue | D005221 | — | R53.83 | 1 | 5 | — | — | 14 | 19 |
Oxidative stress | D018384 | EFO_1001905 | — | 3 | 3 | — | — | 8 | 12 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 5 | 5 | — | — | 2 | 9 |
Sclerosis | D012598 | — | — | 2 | 7 | — | — | 1 | 8 |
Cocaine-related disorders | D019970 | — | F14 | 2 | 7 | — | — | — | 8 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 6 | — | — | 1 | 7 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 2 | — | — | 4 | 7 |
Gastrointestinal diseases | D005767 | — | — | 1 | 2 | — | — | 5 | 7 |
Gastrointestinal microbiome | D000069196 | — | — | 3 | 1 | — | — | 4 | 7 |
Probiotics | D019936 | — | — | 1 | 1 | — | — | 4 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcopenia | D055948 | EFO_1000653 | M62.84 | 1 | — | — | — | 10 | 11 |
Pharmacokinetics | D010599 | — | — | 5 | — | — | — | — | 5 |
Autism spectrum disorder | D000067877 | — | F84.0 | 1 | — | — | — | 4 | 5 |
Goiter | D006042 | EFO_0004283 | E04.9 | 1 | — | — | — | 3 | 4 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | 2 | — | — | — | 2 | 4 |
Colitis | D003092 | EFO_0003872 | K52.9 | 2 | — | — | — | 2 | 4 |
Lipid metabolism disorders | D052439 | — | — | 1 | — | — | — | 2 | 3 |
Thyroid diseases | D013959 | — | E00-E07 | 1 | — | — | — | 2 | 3 |
Muscular atrophy | D009133 | — | — | 2 | — | — | — | — | 2 |
Heartburn | D006356 | — | R12 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Affect | D000339 | — | — | — | — | — | — | 8 | 8 |
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 6 | 6 |
Psychological well-being | D000092862 | — | — | — | — | — | — | 5 | 5 |
Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | — | 4 | 4 |
Surgical wound | D000072836 | — | — | — | — | — | — | 4 | 4 |
Psychological stress | D013315 | — | — | — | — | — | — | 4 | 4 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 4 | 4 |
Alopecia | D000505 | — | L64 | — | — | — | — | 4 | 4 |
Healthy diet | D000072001 | — | — | — | — | — | — | 4 | 4 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | — | — | — | 3 | 3 |
Drug common name | Powdered cellulose |
INN | _ |
Description | Lacrisert (microcrystalline cellulose) is an insert placed in the eye to treat moderate to severe dry eyes. It also can be used to treat the following eye conditions: exposure keratitis, decreased corneal sensitivity and recurrent corneal erosions. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297557 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | ZY7ZTE7LFH (ChemIDplus, GSRS) |